Nerve growth factor (beta-NGF) is known to have beneficial effects on cholinergic cell survival and to function both in vivo and in vitro. It has been speculated that this protein, or the lack of it, may be involved in the aetiology of Alzheimer's disease (AD). We describe the measurement of beta-NGF content in 4 regions of the cerebral cortex and the hippocampus in AD brain compared with brain tissue from age-matched normal subjects using a sensitive sandwich immunoassay (ELISA). There was no difference in beta-NGF content in any region examined in AD compared with normal values despite the marked loss of cortical cholinergic function
Normal aged human basal forebrain tissue immunohistochemically stained with a monoclonal antibody fo...
Basal forebrain neuronal atrophy in Alzheimer\u27s disease (AD) may be caused by a deficit in the NG...
A number of important neurotransmitter deficiencies have been described in Alzheimer's disease, the ...
The current study analyzed NGF protein levels in the brains of patients with Alzheimer\u27s disease ...
Background: The status of nerve growth factor (NGF) levels during the prodromal phase of Alzheimer d...
The binding characteristics of radiolabelled beta-nerve growth factor ([125I]NGF) have been determin...
The cause of the loss of basal forebrain cholinergic neurons (BFCNs) and their terminal synapses in ...
Magnocelular neurons comprising the Ch1-Ch4 regions of the basal forebrain provide topographic choli...
NGF immunohistochemistry was combined with quantitative optical densitometry to evaluate whether ret...
Nerve growth factor (NGF) is critical for the regulation, differentiation, and survival of basal for...
Dysfunction of nerve growth factor (NGF) and its high (TrkA) and low (p75NTR) affinity receptors has...
1. Alzheimer's disease (AD) is pathologically defined by the deposition of amyloid peptide and neuro...
Previous investigations have demonstrated an almost exclusive coupling between the receptor for ne...
Over the past decade, neurotrophic factors have generated much excitement for their potential as the...
Using a monoclonal antibody directed against the primate nerve growth factor (NGF) receptor, we exam...
Normal aged human basal forebrain tissue immunohistochemically stained with a monoclonal antibody fo...
Basal forebrain neuronal atrophy in Alzheimer\u27s disease (AD) may be caused by a deficit in the NG...
A number of important neurotransmitter deficiencies have been described in Alzheimer's disease, the ...
The current study analyzed NGF protein levels in the brains of patients with Alzheimer\u27s disease ...
Background: The status of nerve growth factor (NGF) levels during the prodromal phase of Alzheimer d...
The binding characteristics of radiolabelled beta-nerve growth factor ([125I]NGF) have been determin...
The cause of the loss of basal forebrain cholinergic neurons (BFCNs) and their terminal synapses in ...
Magnocelular neurons comprising the Ch1-Ch4 regions of the basal forebrain provide topographic choli...
NGF immunohistochemistry was combined with quantitative optical densitometry to evaluate whether ret...
Nerve growth factor (NGF) is critical for the regulation, differentiation, and survival of basal for...
Dysfunction of nerve growth factor (NGF) and its high (TrkA) and low (p75NTR) affinity receptors has...
1. Alzheimer's disease (AD) is pathologically defined by the deposition of amyloid peptide and neuro...
Previous investigations have demonstrated an almost exclusive coupling between the receptor for ne...
Over the past decade, neurotrophic factors have generated much excitement for their potential as the...
Using a monoclonal antibody directed against the primate nerve growth factor (NGF) receptor, we exam...
Normal aged human basal forebrain tissue immunohistochemically stained with a monoclonal antibody fo...
Basal forebrain neuronal atrophy in Alzheimer\u27s disease (AD) may be caused by a deficit in the NG...
A number of important neurotransmitter deficiencies have been described in Alzheimer's disease, the ...